$20.47
+0.75 (+3.80%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
+53.68%
YTD
+25.81%
Open$19.99
Previous Close$19.72
Day High$20.55
Day Low$19.40
52W High$27.30
52W Low$12.58
Volume—
Avg Volume1.46M
Market Cap3.22B
P/E Ratio—
EPS$-2.84
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$18.67
Above
SMA 200
$15.96
Above
RSI (14)
42.3
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
26 analysts
Price Target
+274.0% upside
Current
$20.47
$20.47
Target
$76.55
$76.55
$56.04
$76.55 avg
$105.76
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 267.02M | 243.47M | 233.58M |
| Net Income | 59.27M | 48.26M | 42.10M |
| Profit Margin | 22.2% | 19.8% | 18.0% |
| EBITDA | 80.54M | 76.00M | 71.04M |
| Free Cash Flow | 42.58M | 43.55M | 31.33M |
| Rev Growth | -5.4% | -1.1% | +3.4% |
| Debt/Equity | 0.51 | 0.57 | 0.54 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $264.48 | +0.20% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $393.16 | +1.95% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $150.56 | +0.30% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $510.72 | +0.47% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $798.17 | +1.70% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $244.32 | +1.99% | 40.0 | 32.33B |